Combination chemotherapy with carboplatin, paclitaxel and pegylated liposomal doxorubicin for advanced or recurrent carcinosarcoma of the uterus: Clinical experience of a single institution

Gynecologic Oncology

Volumn 110, Issue 3, 2008, Pages 299-303

  Pectasides, Dimitrios ^a   Pectasides, Eirini ^a   Papaxoinis, George ^a   Xiros, Nikolaos ^a   Sykiotis, Constantinos ^a   Papachristodoulou, Antonios ^a   Tountas, Nikolaos ^a   Panayiotides, John ^a   Economopoulos, Theofanis ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Carboplatin; Chemotherapy; Paclitaxel; Pegylated liposomal doxorubicin; Uterine carcinosarcoma

Indexed keywords

ANTIBIOTIC AGENT; ANTIEMETIC AGENT; CARBOPLATIN; DOXORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; PACLITAXEL;

ADULT; ADVANCED CANCER; AGED; ALLERGIC REACTION; ALOPECIA; ANEMIA; ANTIBIOTIC THERAPY; AREA UNDER THE CURVE; ARTHRALGIA; ARTICLE; BONE MARROW TOXICITY; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RECURRENCE; CARCINOSARCOMA; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG WITHDRAWAL; FEBRILE NEUTROPENIA; FEMALE; GRANULOCYTOPENIA; HUMAN; KIDNEY DISEASE; LEUKOPENIA; LIVER DISEASE; LIVER TOXICITY; MULTIPLE CYCLE TREATMENT; MYALGIA; NAUSEA AND VOMITING; NEUROTOXICITY; OVERALL SURVIVAL; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; SKIN DISEASE; STATISTICAL SIGNIFICANCE; STOMATITIS; THROMBOCYTOPENIA; TREATMENT DURATION; UTERUS CARCINOMA; UTERUS SARCOMA;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOSARCOMA; DISEASE-FREE SURVIVAL; DOXORUBICIN; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PACLITAXEL; POLYETHYLENE GLYCOLS; RETROSPECTIVE STUDIES; SURVIVAL RATE; UTERINE NEOPLASMS;

EID: 50349098505     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2008.05.017     Document Type: Article

References (22)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2008. CA Cancer J. Clin. 58 (2008) 71-96
2. Clement P.B. Müllerian adenosarcomas of the uterus with sarcomatous overgrowth. A clinicopathological analysis of 10 cases. Am. J. Surg. Pathol. 13 (1989) 28-38
3. Major F.J., Blessing J.A., Silverberg S.G., et al. Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group study. Cancer 71 (1993) 1702-1709
4. Reed N.S., Mangioni C., Malmström H., et al. Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: a European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874). Eur. J. Cancer 44 (2008) 808-818
5. Le T. Adjuvant pelvic radiotherapy for uterine carcinosarcoma in a high risk population. Eur. J. Surg. Oncol. 27 (2001) 282-285
6. Chi D.S., Mychalczak B., Saigo P.E., Rescigno J., and Brown C.L. The role of whole-pelvic irradiation in the treatment of early-stage uterine carcinosarcoma. Gynecol. Oncol. 65 (1997) 493-498
7. Omura G.A., Major F.J., Blessing J.A., et al. A randomized study of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomas. Cancer 52 (1983) 626-632
8. Muss H.B., Bundy B., DiSaia P.J., et al. Treatment of recurrent or advanced uterine sarcoma. A randomized trial of doxorubicin versus doxorubicin and cyclophosphamide (a phase III trial of the Gynecologic Oncology Group). Cancer 55 (1985) 1648-1653
9. Sutton G.P., Blessing J.A., Rosenshein N., Photopoulos G., and DiSaia P.J. Phase II trial of ifosfamide and mesna in mixed mesodermal tumors of the uterus (a Gynecologic Oncology Group study). Am. J. Obstet. Gynecol. 161 (1989) 309-312
10. Sutton G., Brunetto V.L., Kilgore L., et al. A phase III trial of ifosfamide with or without cisplatin in carcinosarcoma of the uterus: a Gynecologic Oncology Group Study. Gynecol. Oncol. 79 (2000) 147-153
11. Curtin J.P., Blessing J.A., Soper J.T., and DeGeest K. Paclitaxel in the treatment of carcinosarcoma of the uterus: a gynecologic oncology group study. Gynecol. Oncol. 83 (2001) 268-270
12. Thigpen J.T., Blessing J.A., Orr Jr. J.W., and DiSaia P.J. Phase II trial of cisplatin in the treatment of patients with advanced or recurrent mixed mesodermal sarcomas of the uterus: a Gynecologic Oncology Group Study. Cancer Treat. Rep. 70 (1986) 271-274
13. Thigpen J.T., Blessing J.A., Beecham J., Homesley H., and Yordan E. Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent uterine sarcomas: a Gynecologic Oncology Group study. J. Clin. Oncol. 9 (1991) 1962-1966
14. del Carmen M.G., Lovett D., and Goodman A. A case of Müllerian adenosarcoma of the uterus treated with liposomal doxorubicin. Gynecol. Oncol. 88 (2003) 456-458
15. van Rijswijk R.E., Vermorken J.B., Reed N., et al. Cisplatin, doxorubicin and ifosfamide in carcinosarcoma of the female genital tract. A phase II study of the European Organization for Research and Treatment of Cancer Gynaecological Cancer Group (EORTC 55923). Eur. J. Cancer 39 (2003) 481-487
16. McCluggage W.G. Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomas. Int. J. Gynecol. Cancer 12 (2002) 687-690
17. Pectasides D., Xiros N., Papaxoinis G., et al. Carboplatin and paclitaxel in advanced or metastatic endometrial cancer. Gynecol. Oncol. (2008 Feb 23) Ahead of print
18. Takada S., Tamura A., Hiraoka K., Ogino M., Mori H., and Imamura T. A case of remission of recurrent carcinosarcoma of the uterus with massive ascites by carboplatin. Gan To Kagaku Ryoho 22 (1995) 1253-1256
19. Toyoshima M., Akahira J., Matsunaga G., et al. Clinical experience with combination paclitaxel and carboplatin therapy for advanced or recurrent carcinosarcoma of the uterus. Gynecol. Oncol. 94 (2004) 774-778
20. Iwasa Y., Haga H., Konishi I., et al. Prognostic factors in uterine carcinosarcoma: a clinicopathologic study of 25 patients. Cancer 82 (1998) 512-519
21. Homesley H.D., Filiaci V., Markman M., et al. Phase III trial of ifosfamide with or without paclitaxel in advanced uterine carcinosarcoma: a Gynecologic Oncology Group Study. J. Clin. Oncol. 25 (2007) 526-531
22. Wolfson A.H., Brady M.F., Rocereto T., et al. A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I-IV carcinosarcoma (CS) of the uterus. Gynecol. Oncol. 107 (2007) 177-185